mibefradil has been researched along with Chronic Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (73.33) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, L; Liu, HF; Liu, TT; Shu, Y; Xiao, B | 1 |
| Wang, J; Wang, XW; Yin, CP; Yue, SW; Zhang, Y | 1 |
| Bakx, AL; Braun, S; Bruschke, AV; Emanuelsson, H; Kobrin, I; van der Wall, EE | 1 |
| Alpert, JS; DeQuattro, V; Fenster, PE; Friedman, R; Kobrin, I; Shepherd, A; Thadani, U | 1 |
| Alpert, JS; Bakx, AL; Braun, S; Frishman, WH; Kobrin, I; Schneeweiss, A; Tzivoni, D | 1 |
| Davies, GJ; Kobrin, I; Tzivoni, D | 1 |
| Charlon, V; Kobrin, I; Lindberg, E; Pordy, R | 1 |
| Alpert, JS | 1 |
| Mulder, P; Richard, V; Thuillez, C | 1 |
| Massie, BM | 1 |
| Bittar, N; Frishman, WH; Glasser, S; Habib, G; Pordy, R; Smith, W | 1 |
| Charlon, V; Kobrin, I | 1 |
| Meissner, A; Min, JY; Sandmann, S; Simon, R; Unger, T | 1 |
| Antman, EM; Marsh, JD | 1 |
| Baylis, C; Engels, K; Qiu, C | 1 |
1 review(s) available for mibefradil and Chronic Disease
| Article | Year |
|---|---|
Mibefradil, a T-type channel-selective calcium antagonist: clinical trials in chronic stable angina pectoris.
Topics: Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Clinical Trials as Topic; Diltiazem; Humans; Mibefradil; Tetrahydronaphthalenes | 1998 |
8 trial(s) available for mibefradil and Chronic Disease
| Article | Year |
|---|---|
Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exercise duration in patients with chronic stable angina pectoris: a multicenter, placebo-controlled study. Ro 40-5967 International Study Group.
Topics: Adult; Aged; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Placebos; Tetrahydronaphthalenes; Time Factors | 1995 |
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Exercise Test; Female; Humans; Male; Mibefradil; Middle Aged; Tetrahydronaphthalenes; Treatment Outcome; Vasodilator Agents | 1997 |
Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Tetrahydronaphthalenes | 1997 |
Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Diltiazem; Female; Hemodynamics; Humans; Male; Mibefradil; Middle Aged; Nitroglycerin; Tetrahydronaphthalenes | 1997 |
Safety of mibefradil, a new once-a-day, selective T-type calcium channel antagonist.
Topics: Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Drug Administration Schedule; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Hypertension; Male; Mibefradil; Middle Aged; Nifedipine; Tetrahydronaphthalenes | 1997 |
Treatment of chronic angina pectoris with combination mibefradil and beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Tolerance; Humans; Mibefradil; Propranolol; Safety; Tetrahydronaphthalenes; Treatment Outcome | 1998 |
Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Tolerance; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Mibefradil; Middle Aged; Nitroglycerin; Prospective Studies; Safety; Tetrahydronaphthalenes; Treatment Outcome; Vasodilator Agents | 1998 |
The efficacy and safety of mibefradil in subgroups of patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Benzimidazoles; Body Weight; Calcium Channel Blockers; Chronic Disease; Exercise Test; Female; Humans; Male; Mibefradil; Middle Aged; Sex Factors; Tetrahydronaphthalenes; Treatment Outcome | 1998 |
6 other study(ies) available for mibefradil and Chronic Disease
| Article | Year |
|---|---|
Altered axon initial segment in hippocampal newborn neurons, associated with recurrence of temporal lobe epilepsy in rats.
Topics: Animals; Axon Initial Segment; Behavior, Animal; Cell Proliferation; Chronic Disease; Dendrites; Dentate Gyrus; Doublecortin Protein; Electroencephalography; Epilepsy, Temporal Lobe; Hippocampus; Male; Mibefradil; Neurogenesis; Pilocarpine; Rats, Sprague-Dawley; Recurrence | 2017 |
Ca(2+) influx mediates the TRPV4-NO pathway in neuropathic hyperalgesia following chronic compression of the dorsal root ganglion.
Topics: Animals; Calcium; Calcium Channel Blockers; Chronic Disease; Ganglia, Spinal; Hyperalgesia; Male; Mibefradil; Nerve Compression Syndromes; Neuralgia; NF-kappa B; Nitric Oxide; Phorbols; Rats, Wistar; RNA, Small Interfering; Signal Transduction; TRPV Cation Channels | 2015 |
Different effects of calcium antagonists in a rat model of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Calcium Channel Blockers; Catecholamines; Chronic Disease; Cilazapril; Heart Failure; Heart Ventricles; Hemodynamics; Male; Mibefradil; Myocardial Contraction; Random Allocation; Rats; Rats, Wistar; Renin; Survival Rate; Tetrahydronaphthalenes | 1998 |
Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
Topics: Adrenergic beta-Agonists; Aequorin; Amlodipine; Animals; Calcium; Calcium Channel Blockers; Chronic Disease; Heart; Heart Function Tests; Hemodynamics; Isometric Contraction; Isoproterenol; Male; Mibefradil; Myocardial Contraction; Myocardial Infarction; Myocardium; Papillary Muscles; Rats; Rats, Wistar; Verapamil | 1999 |
T-type calcium channel blockade in the management of chronic ischemic heart disease.
Topics: Calcium Channel Blockers; Calcium Channels; Chronic Disease; Drug Interactions; Heart Rate; Humans; Mibefradil; Myocardial Ischemia | 2000 |
Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Chronic Disease; Desoxycorticosterone; Hypertension, Renovascular; Kidney Diseases; Kidney Glomerulus; Male; Mibefradil; Proteinuria; Rats; Rats, Sprague-Dawley | 2001 |